Clinical Trial Update: Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-251 in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update evaluating the safety, tolerability, pharmacodynamics, efficacy, and pharmacokinetics of DYNE-251 in Duchenne muscular dystrop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• DYNE-251

Snippet

Sponsor: Dyne Therapeutics | Conditions: Duchenne Muscular Dystrophy (DMD) | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING